BlackRock Investment Management’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$22M Buy
329,931
+55,779
+20% +$3.63M 0.03% 626
2016
Q3
$18.2M Sell
274,152
-4,120
-1% -$282K 0.02% 645
2016
Q2
$20.2M Buy
278,272
+5,247
+2% +$361K 0.03% 559
2016
Q1
$17.6M Sell
273,025
-4,767
-2% -$316K 0.02% 630
2015
Q4
$19.9M Buy
277,792
+10,222
+4% +$756K 0.03% 573
2015
Q3
$20.5M Sell
267,570
-1,812
-0.7% -$146K 0.03% 536
2015
Q2
$20M Buy
269,382
+3,124
+1% +$225K 0.02% 585
2015
Q1
$19.3M Sell
266,258
-9,414
-3% -$655K 0.03% 582
2014
Q4
$18.2M Sell
275,672
-2,331
-0.8% -$142K 0.02% 593
2014
Q3
$15.2M Buy
278,003
+2,662
+1% +$151K 0.02% 666
2014
Q2
$16M Sell
275,341
-7,374
-3% -$434K 0.02% 663
2014
Q1
$17.5M Sell
282,715
-2,141
-0.8% -$125K 0.03% 580
2013
Q4
$15.2M Sell
284,856
-4,050
-1% -$217K 0.02% 635
2013
Q3
$14.5M Buy
288,906
+28,876
+11% +$1.41M 0.02% 613
2013
Q2
$11.9M Buy
+260,030
New +$11.6M 0.02% 662

Other funds holding MD

BlackRock Investment Management's MD Position: Q4 2016 in Review

BlackRock Investment Management increased its Pediatrix Medical (MD) stake by 20% in Q4 2016, buying an estimated $3.63M and bringing the position to 329,931 shares worth $22M. The position accounts for 0.03% of the portfolio, ranked #626.

BlackRock Investment Management first reported a position in MD in Q2 2013 and has held it in 15 quarters since. 383 funds tracked by Wall St. Rank hold MD as of Q4 2016.

  • BlackRock Investment Management held 329,931 shares of Pediatrix Medical worth $22M as of Q4 2016.
  • BlackRock Investment Management bought 55,779 Pediatrix Medical shares in Q4 2016, an estimated $3.63M.
  • Pediatrix Medical made up 0.03% of BlackRock Investment Management's portfolio in Q4 2016, its #626 holding.
  • BlackRock Investment Management first reported a position in Pediatrix Medical in Q2 2013 and has held it in 15 quarters since.
  • 383 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.